Kangji Medical Holdings Future Growth
Future criteria checks 3/6
Kangji Medical Holdings is forecast to grow earnings and revenue by 14.5% and 17.9% per annum respectively while EPS is expected to grow by 14.3% per annum.
Key information
14.5%
Earnings growth rate
14.3%
EPS growth rate
| Medical Equipment earnings growth | 35.1% |
| Revenue growth rate | 17.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 19 May 2024 |
Recent future growth updates
Recent updates
Investors Could Be Concerned With Kangji Medical Holdings' (HKG:9997) Returns On Capital
Apr 12
Kangji Medical Holdings Limited (HKG:9997) Shares Could Be 32% Above Their Intrinsic Value Estimate
Mar 08Kangji Medical Holdings Limited's (HKG:9997) Share Price Not Quite Adding Up
Dec 21Kangji Medical Holdings' (HKG:9997) Returns On Capital Not Reflecting Well On The Business
Oct 23Should You Be Adding Kangji Medical Holdings (HKG:9997) To Your Watchlist Today?
Aug 17A Look At The Intrinsic Value Of Kangji Medical Holdings Limited (HKG:9997)
Jul 28Kangji Medical Holdings (HKG:9997) Will Be Hoping To Turn Its Returns On Capital Around
May 16Is Now The Time To Put Kangji Medical Holdings (HKG:9997) On Your Watchlist?
May 01Some Shareholders Feeling Restless Over Kangji Medical Holdings Limited's (HKG:9997) P/E Ratio
Apr 13A Look At The Fair Value Of Kangji Medical Holdings Limited (HKG:9997)
Mar 28Here's Why Kangji Medical Holdings (HKG:9997) Has Caught The Eye Of Investors
Jan 03Are Kangji Medical Holdings Limited (HKG:9997) Investors Paying Above The Intrinsic Value?
Sep 21Kangji Medical Holdings (HKG:9997) Is Reinvesting At Lower Rates Of Return
Jun 12Kangji Medical Holdings' (HKG:9997) Shareholders Will Receive A Bigger Dividend Than Last Year
May 16Kangji Medical Holdings (HKG:9997) Will Pay A Larger Dividend Than Last Year At HK$0.17
May 02Returns On Capital At Kangji Medical Holdings (HKG:9997) Paint A Concerning Picture
Dec 20Analysts Just Slashed Their Kangji Medical Holdings Limited (HKG:9997) EPS Numbers
Mar 31Here's Why We Think Kangji Medical Holdings' (HKG:9997) Statutory Earnings Might Be Conservative
Feb 03
Does Kangji Medical Holdings Limited (HKG:9997) Create Value For Shareholders?
Dec 30An Intrinsic Calculation For Kangji Medical Holdings Limited (HKG:9997) Suggests It's 42% Undervalued
Nov 25Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,624 | 785 | N/A | N/A | 1 |
| 12/31/2025 | 1,345 | 669 | N/A | N/A | 2 |
| 12/31/2024 | 1,134 | 569 | N/A | N/A | 2 |
| 12/31/2023 | 926 | 504 | 333 | 420 | N/A |
| 9/30/2023 | 892 | 540 | 312 | 390 | N/A |
| 6/30/2023 | 858 | 576 | 291 | 360 | N/A |
| 3/31/2023 | 822 | 528 | 267 | 340 | N/A |
| 12/31/2022 | 786 | 479 | 242 | 319 | N/A |
| 9/30/2022 | 745 | 447 | 261 | 326 | N/A |
| 6/30/2022 | 704 | 415 | 281 | 332 | N/A |
| 3/31/2022 | 697 | 436 | 343 | 384 | N/A |
| 12/31/2021 | 690 | 457 | 405 | 436 | N/A |
| 9/30/2021 | 654 | 413 | 379 | 405 | N/A |
| 6/30/2021 | 617 | 369 | 353 | 374 | N/A |
| 3/31/2021 | 564 | 310 | 278 | 298 | N/A |
| 12/31/2020 | 511 | 250 | 203 | 221 | N/A |
| 9/30/2020 | 506 | 227 | 246 | 261 | N/A |
| 6/30/2020 | 500 | 204 | 290 | 301 | N/A |
| 3/31/2020 | 502 | 205 | 303 | 313 | N/A |
| 12/31/2019 | 503 | 206 | 316 | 326 | N/A |
| 12/31/2018 | 354 | 147 | 189 | 205 | N/A |
| 12/31/2017 | 248 | 118 | 136 | 143 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 9997's forecast earnings growth (14.5% per year) is above the savings rate (2.2%).
Earnings vs Market: 9997's earnings (14.5% per year) are forecast to grow faster than the Hong Kong market (11.2% per year).
High Growth Earnings: 9997's earnings are forecast to grow, but not significantly.
Revenue vs Market: 9997's revenue (17.9% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).
High Growth Revenue: 9997's revenue (17.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 9997's Return on Equity is forecast to be high in 3 years time